<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02852044</url>
  </required_header>
  <id_info>
    <org_study_id>RE-CP</org_study_id>
    <nct_id>NCT02852044</nct_id>
  </id_info>
  <brief_title>The Influence of Sampling Site When Assessing Glucose Tolerance or Insulin Sensitivity With Oral Glucose Ingestion</brief_title>
  <official_title>The Influence of Sampling Site When Assessing Glucose Tolerance or Insulin Sensitivity With Oral Glucose Ingestion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bath</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Bath</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      For decades, it has been known that post-meal blood glucose concentrations were associated
      with the risk of T2D, which was reflected in early diagnostic guidelines. The oral glucose
      tolerance test (OGTT) has been used since at least 1923 and has remained the most common test
      for assessing glucose tolerance. Arterial blood (or arterialised blood using heated hand
      technique) is most appropriate for determining glucose tolerance and insulin sensitivity
      since this best represents the concentrations of metabolites and hormones that peripheral
      tissues are exposed to. It is essential to investigate whether venous blood (sometimes used
      during an OGTT) is representative of arterialised blood during an OGTT, and under different
      metabolic conditions.

      The investigators want to understand whether OGTT-derived insulin sensitivity indices differ
      from venous and arterialised blood; and 2) investigate whether metabolic status (i.e. rest vs
      lower-limb exercise) influences the difference between forearm venous and arterialised
      concentrations of glucose and insulin during an OGTT.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postprandial plasma glucose concentrations (area under the concentration-time curve)</measure>
    <time_frame>120 mins</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>OGTT-derived insulin sensitivity</measure>
    <time_frame>120 mins</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fasting plasma glucose concentrations</measure>
    <time_frame>5 mins</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting plasma insulin concentrations</measure>
    <time_frame>5 mins</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting plasma lactate concentrations</measure>
    <time_frame>5 mins</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting plasma triglyceride concentrations</measure>
    <time_frame>5 mins</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial plasma lactate concentrations (area under the concentration-time curve)</measure>
    <time_frame>120 mins</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial plasma triglyceride concentrations (area under the concentration-time curve)</measure>
    <time_frame>120 mins</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Substrate utilization for energy provision</measure>
    <time_frame>180 mins</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial plasma insulin concentrations (area under the concentration-time curve)</measure>
    <time_frame>120 mins</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Hyperglycemia</condition>
  <condition>Insulin Sensitivity</condition>
  <arm_group>
    <arm_group_label>Rest</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Remain rested prior to the oral glucose tolerance test</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Complete exercise prior to the oral glucose tolerance test</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Rest</intervention_name>
    <description>Allowed to watch television or read for one hour prior to oral glucose tolerance test</description>
    <arm_group_label>Rest</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>One hour of cycling at 50% of maximal power output</description>
    <arm_group_label>Exercise</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dorsal Hand Vein Cannulation (heated hand technique)</intervention_name>
    <arm_group_label>Rest</arm_group_label>
    <arm_group_label>Exercise</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Venous Cannulation</intervention_name>
    <arm_group_label>Rest</arm_group_label>
    <arm_group_label>Exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 18-49 years

          -  Able and willing to safely comply with all study procedures

          -  Able to provide written informed consent for participation

        Exclusion Criteria:

          -  Diagnosis of any bleeding disorder or taking medication which impacts blood
             coagulation

          -  The presence of any contraindications to maximal exercise testing, as determined using
             a physical activity readiness questionnaire (PAR-Q).

          -  Any diagnosis of metabolic disease (i.e. cardiovascular disease or type 2 diabetes).
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department for Health, University of Bath</name>
      <address>
        <city>Bath</city>
        <zip>BA2 7AY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Nauck MA, Liess H, Siegel EG, Niedmann PD, Creutzfeldt W. Critical evaluation of the 'heated-hand-technique' for obtaining 'arterialized' venous blood: incomplete arterialization and alterations in glucagon responses. Clin Physiol. 1992 Sep;12(5):537-52.</citation>
    <PMID>1395446</PMID>
  </reference>
  <reference>
    <citation>Liu D, Moberg E, Kollind M, Lins PE, Adamson U, Macdonald IA. Arterial, arterialized venous, venous and capillary blood glucose measurements in normal man during hyperinsulinaemic euglycaemia and hypoglycaemia. Diabetologia. 1992 Mar;35(3):287-90.</citation>
    <PMID>1563586</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 28, 2016</study_first_submitted>
  <study_first_submitted_qc>August 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 2, 2016</study_first_posted>
  <last_update_submitted>October 24, 2016</last_update_submitted>
  <last_update_submitted_qc>October 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Bath</investigator_affiliation>
    <investigator_full_name>Javier Gonzalez</investigator_full_name>
    <investigator_title>Lecturer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

